2020
DOI: 10.1007/s00204-020-02858-4
|View full text |Cite
|
Sign up to set email alerts
|

Functional basis for dose-dependent antagonism of rat and rabbit neuromuscular transmission by the bis-pyridinium oxime MMB4

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 60 publications
0
3
0
Order By: Relevance
“…Methoxime, or MMB-4, is a bis-pyridinium oxime that has shown improved pharmaceutical properties and therapeutic range compared to 2-PAM and obidoxime ( Lundy et al, 2011 ; Machamer et al, 2020 ). In addition, Asoxime Chloride (HI-6) is a substantially broad-spectrum AChE reactivator, and a double-positive charged bispyridinium compound, commonly used in Canada, Sweden, and the Czech Republic.…”
Section: Methodsmentioning
confidence: 99%
“…Methoxime, or MMB-4, is a bis-pyridinium oxime that has shown improved pharmaceutical properties and therapeutic range compared to 2-PAM and obidoxime ( Lundy et al, 2011 ; Machamer et al, 2020 ). In addition, Asoxime Chloride (HI-6) is a substantially broad-spectrum AChE reactivator, and a double-positive charged bispyridinium compound, commonly used in Canada, Sweden, and the Czech Republic.…”
Section: Methodsmentioning
confidence: 99%
“…This double positive charged bis-pyridinium compound has been shown to be effective in the treatment of neural factors [ 48 , 49 ]. A bis-pyridinium oxime with superior therapeutic and pharmaceutical properties compared to both obidoxime and 2-PAM is a methoxime (MMB-4) [ 50 ]. An oxime with restricted use due to CNS and hepatotoxic side effects is thimodexime bromide (TMB-4) despite its effectiveness in reactivating AChE [ 51 ].…”
Section: Treatment Of Novichok Exposure: Where To Start?mentioning
confidence: 99%
“…Since 2018, in the toxicological literature, the following lines of investigation can be identified, which are reflected by key contributions to Archives of Toxicology. Clinical reports (Novichok) and improvement of therapy of intoxications by organophosphorus compounds (Hulse et al 2019 ; Steindl et al 2021 ; Vale et al 2018 ; Worek et al 2020 ; Zandona et al 2020 , 2021 ): a special focus is development of novel antidotes, e.g., novel oximes (Machamer et al 2020 ; Zandona et al 2020 , 2021 ) or engineered phoshotriesterases (Stigler et al 2021 ). Given the world-wide incidents attributed to chemical weapons, such as Novichok agents, intensive-care clinicians should know how to rapidly recognize symptoms of acute poisoning and to administer life-saving antidotal therapy, when indicated (Chai et al 2018 ).…”
mentioning
confidence: 99%